Sort
82,697 grants matching “vaccine development”
Engineering protease-resistant alpha-beta peptides for broad-spectrum antivirals
$766,098Anne Moscona · Columbia University Health Sciences · R01 · FY2016 · AI
Household Transmission of Cryptosporidium
$766,095Poonum S. Korpe · Johns Hopkins University · R01 · FY2019 · AI
Harnessing NK Memory to Protect Against HIV Infection
$766,092Silke Paust · Scripps Research Institute, The · R01 · FY2019 · AI
Vector Biological Studies in Leishmaniasis
$766,082David Sacks · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Evaluation of pregnancy on vaccine-induced immunity and protection in a pre-clinical model of RSV infection
$766,079Karen A Norris · University Of Georgia · R01 · FY2023 · AI
Sex specific immune response to SARS-CoV-2 leads to chronic neurologic symptoms
$766,078Louise Deborah McCullough · University Of Texas Hlth Sci Ctr Houston · R01 · FY2021 · MH
Novel nanobodies to prevent and treat SARS-CoV-2 and other pathogenic human coronaviruses
$766,055Lanying Du · Georgia State University · R01 · FY2021 · AI
IMPDH inhibitors for the treatment of Cryptosporidium infections
$766,043Gregory D Cuny · University Of Houston · R01 · FY2019 · AI
Development of Fully Human mAbs as Anthrax Antitoxins
$766,020Israel Lowy · Medarex, Inc. · U01 · FY2006 · AI
The Lymphoid Tissue Pharmacology of Antiretroviral Drugs
$765,790Courtney V. Fletcher · University Of Nebraska Medical Center · R01 · FY2016 · AI
Neonatal Immunity to novel TF SHIVs
$765,777Wilton B Williams · Duke University · R01 · FY2020 · AI
Epigenetic Regulation of Normal and Pathologic CTCF Functions by BORIS
$765,771Victor Lobanenkov · National Institute Of Allergy And Infectious Diseases · ZIA · FY2013 · AI
Quantiferon Gold Test for Detecting TB Infection in HIV/AIDS Patients in Brazil
$765,732Jonathan E Golub · Johns Hopkins University · R01 · FY2016 · AI
Protecutive immunity to human cholera in Bangladesh
$765,601Stephen B. Calderwood · Massachusetts General Hospital · U01 · FY2010 · AI
(PQB-3) Driver gene-induced inflammation in pancreatic cancer development
$765,544Elizabeth Marion Jaffee · Johns Hopkins University · R01 · FY2017 · CA
Defining the protective efficacy of antibodies against the EBV gH/gL glycoprotein complex
$765,542Andrew McGuire · Fred Hutchinson Cancer Research Center · R01 · FY2019 · AI
A dual function TB subunit vaccine designed for non-interference with BCG and post-exposure activity
$765,521Rasmus Skaarup Mortensen · Statens Serum Institute · R01 · FY2020 · AI
Core B - Functional Immunology Core (CIIG)
$765,473Alison K Criss · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2025 · AI
Innate Immunity
$765,429Bali Pulendran · Emory University · U19 · FY2009 · AI
The Consequences of Reinfection with M. tuberculosis
$765,415Joanne L. Flynn · University Of Pittsburgh At Pittsburgh · R01 · FY2016 · AI
Preventing TB with intravenous BCG in SIV-infected macaques
$765,413Charles A. Scanga · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · AI
Immune reconstitution following autologous and allogeneic stem cell transplant
$765,402Frances Hakim · Division Of Basic Sciences - Nci · ZIC · FY2009 · CA
Evaluation of the Immunogenicity and Efficacy of HIV-1 Clade A BG505 SOSIP.664 Env Glycoprotein Trimer Vaccine Administered with TLR Agonist or Alum Adjuvants
$765,335Maria Grazia Ferrari · Bioqual, Inc. · N01 · FY2022 · AI
Baltimore Acute Hepatitis C Cooperative Center
$765,313Andrea L Cox · Johns Hopkins University · U19 · FY2011 · AI
Nonhuman Primate Core Virology Laboratory for AIDS Vaccine Research and Development
$765,309Thomas Denny · Duke University · N01 · FY2021 · AI